An analysis of disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019_Chinese Journal of Evidence-Based Medicine

Authors：

LUO Lisha ¹ ^# , LUAN Hanghang ² , ZHENG Hang ³ , WANG Yongbo ¹ , ZHU Cong ^1,3 , LI Binghui ^1,3 , ZI Hao ^1,3 ,  ZENG Xiantao ¹

1. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China;
2. Department of Forensic Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China;
3. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China;

Corresponding?author：

ZENG Xiantao, Email: zengxiantao1128@163.com

Keywords：

Prostate cancer; Bladder cancer; Kidney cancer; Smoking; Disease burden

DOI：

10.7507/1672-2531.202201059

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To analyze the disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019. Methods Based on the global burden of disease study 2019, the current situation of the disease burden of prostate, bladder and kidney cancers attributable to smoking was analyzed by using the population attributable fraction (PAF), deaths and disability-adjusted life years (DALYs). Furthermore, the annual percent change (APC) and the average annual percent change (AAPC) were calculated by joinpoint regression analysis to describe the long-term trends of the smoking-attributable burden of these three cancers from 1990 to 2019. Results There were an estimated 18 800 cases of deaths and 393 106 person-years of DALYs for bladder cancer caused by smoking in 2019. The age-standardized mortality and DALY rate decreased by 0.41% and 0.39% per year from 1990 to 2019, respectively. For prostate cancer, smoking was estimated to have caused 5 016 cases of deaths and 98 276 person-years of DALYs in 2019. The age-standardized mortality and DALY rate decreased by 0.28% and 0.25% per year from 1990 to 2019, respectively. For kidney cancer, the deaths and DALYs attributable to smoking were 4 935 cases and 120 620 person-years, respectively. The standardized mortality and DALY rates increased by 3.03% and 2.98% per year from 1990 to 2019. Additionally, males suffered from a higher disease burden of these three cancers attributable to smoking than females. The elderly population had a higher smoking-attributable disease burden than the younger population. Conclusion The situation of the disease burden of bladder, prostate and kidney cancers attributable to smoking is still serious in China, which has substantial disparities in different groups. Specifically, males and the elderly are the high-risk groups for the smoking-attributable burden. Among the three cancers, bladder cancer has the highest burden and kidney cancer has the largest burden increase during 1990-2019.

Citation： LUO Lisha, LUAN Hanghang, ZHENG Hang, WANG Yongbo, ZHU Cong, LI Binghui, ZI Hao, ZENG Xiantao. An analysis of disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019. Chinese Journal of Evidence-Based Medicine, 2022, 22(5): 530-536. doi: 10.7507/1672-2531.202201059 Copy

1.	Zi H, He SH, Leng XY, et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019. Mil Med Res, 2021, 8(1): 60.
2.	鄧通, 蔡林, 陳征, 等. 1990年與2017年中國前列腺癌疾病負擔分析. 醫學新知, 2020, 30(4): 252-259.
3.	訾豪, 彭謀, 王江宜, 等. 1990~2017年中國膀胱癌疾病負擔分析. 醫學新知, 2020, 30(5): 328-335.
4.	GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet, 2020, 396(10258): 1204-1222.
5.	Luo LS, Jiang JF, Luan HH, et al. Spatial and temporal patterns of prostate cancer burden and their association with Socio-Demographic Index in Asia, 1990-2019. Prostate, 2022, 82(2): 193-202.
6.	GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet, 2020, 396(10258): 1223-1249.
7.	GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global burden of disease study 2015. Lancet, 2017, 389(10082): 1885-1906.
8.	顧佳敏, 朱聰, 訾豪, 等. 1990—2019年中國良性前列腺增生疾病負擔分析. 解放軍醫學雜志, 2021, 46(10): 984-988.
9.	王娜, 劉潔, 李曉東, 等. 中國1990—2019年結直腸癌疾病負擔分析. 中國循證醫學雜志, 2021, 21(5): 520-524.
10.	于石成, 肖革新. 全球疾病負擔研究—大數據分析應用實例. 醫學信息學雜志, 2013, 34(9): 12-16.
11.	Wen H, Xie C, Wang F, et al. Trends in disease burden attributable to tobacco in china, 1990-2017: findings from the global burden of disease study 2017. Front Public Health, 2020, 8: 237.
12.	Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000, 19(3): 335-351.
13.	Luan HH, Luo LS, Lu ZY. Historical trends in incidence of breast cancer in Shanghai, Hong Kong and Los Angeles, 1973-2012: a joinpoint and age-period-cohort analysis. Int J Public Health, 2021, 66: 603810.
14.	李新華. 2018中國成人煙草調查報告. 北京: 人民衛生出版社, 2020.
15.	屠夢吳, 南奕, 王立立, 等. 中國成人對煙草危害知曉率的現狀分析. 中國慢性病預防與控制, 2017, 25(6): 404-408.
16.	任新聞, 于石成, 王麗敏, 等. 2018年中國居民歸因于吸煙的腦卒中死亡分析. 中國慢性病預防與控制, 2021, 29(2): 81-84.
17.	楊功煥, 胡鞍鋼. 控煙與中國未來—中外專家中國煙草使用與煙草控制聯合評估報告. 北京: 經濟日報出版社, 2011.
18.	王辰, 肖丹, 池慧. 《中國吸煙危害健康報告2020》概要. 中國循環雜志, 2021, 36(10): 937-952.
19.	姜垣, 劉黎香, 楊焱, 等. 健康中國2030控煙的必由之路. 中國慢性病預防與控制, 2018, 26(4): 241-244.

1. Zi H, He SH, Leng XY, et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019. Mil Med Res, 2021, 8(1): 60.
2. 鄧通, 蔡林, 陳征, 等. 1990年與2017年中國前列腺癌疾病負擔分析. 醫學新知, 2020, 30(4): 252-259.
3. 訾豪, 彭謀, 王江宜, 等. 1990~2017年中國膀胱癌疾病負擔分析. 醫學新知, 2020, 30(5): 328-335.
4. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet, 2020, 396(10258): 1204-1222.
5. Luo LS, Jiang JF, Luan HH, et al. Spatial and temporal patterns of prostate cancer burden and their association with Socio-Demographic Index in Asia, 1990-2019. Prostate, 2022, 82(2): 193-202.
6. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet, 2020, 396(10258): 1223-1249.
7. GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the global burden of disease study 2015. Lancet, 2017, 389(10082): 1885-1906.
8. 顧佳敏, 朱聰, 訾豪, 等. 1990—2019年中國良性前列腺增生疾病負擔分析. 解放軍醫學雜志, 2021, 46(10): 984-988.
9. 王娜, 劉潔, 李曉東, 等. 中國1990—2019年結直腸癌疾病負擔分析. 中國循證醫學雜志, 2021, 21(5): 520-524.
10. 于石成, 肖革新. 全球疾病負擔研究—大數據分析應用實例. 醫學信息學雜志, 2013, 34(9): 12-16.
11. Wen H, Xie C, Wang F, et al. Trends in disease burden attributable to tobacco in china, 1990-2017: findings from the global burden of disease study 2017. Front Public Health, 2020, 8: 237.
12. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000, 19(3): 335-351.
13. Luan HH, Luo LS, Lu ZY. Historical trends in incidence of breast cancer in Shanghai, Hong Kong and Los Angeles, 1973-2012: a joinpoint and age-period-cohort analysis. Int J Public Health, 2021, 66: 603810.
14. 李新華. 2018中國成人煙草調查報告. 北京: 人民衛生出版社, 2020.
15. 屠夢吳, 南奕, 王立立, 等. 中國成人對煙草危害知曉率的現狀分析. 中國慢性病預防與控制, 2017, 25(6): 404-408.
16. 任新聞, 于石成, 王麗敏, 等. 2018年中國居民歸因于吸煙的腦卒中死亡分析. 中國慢性病預防與控制, 2021, 29(2): 81-84.
17. 楊功煥, 胡鞍鋼. 控煙與中國未來—中外專家中國煙草使用與煙草控制聯合評估報告. 北京: 經濟日報出版社, 2011.
18. 王辰, 肖丹, 池慧. 《中國吸煙危害健康報告2020》概要. 中國循環雜志, 2021, 36(10): 937-952.
19. 姜垣, 劉黎香, 楊焱, 等. 健康中國2030控煙的必由之路. 中國慢性病預防與控制, 2018, 26(4): 241-244.

Previous Article
Analysis of disease burden of skin malignant melanoma in China
Next Article
Diagnostic value of miRNAs for Alzheimer’s disease: a meta-analysis

Chinese Journal of Evidence-Based Medicine

An analysis of disease burden of prostate, bladder and kidney cancers attributable to smoking in China from 1990 to 2019

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content